Triptorelin Pamoate (Trelstar®)

Common name: Triptorelin Pamoate
Brand name: Trelstar®
 

What is Triptorelin Pamoate?

Triptorelin is used in the palliative treatment of hormone dependent advanced prostate cancer. It works by reducing the amount testosterone in the blood.
 

How is Triptorelin Pamoate administered?

Triptorelin Pamoate is administered by intramuscular injection.
 

What are possible side effects of this treatment?

Everyone responds differently to hormone therapy – some experience many side effects while others experience very few. Below are some side effects experienced by those who received triptorelin pamoate. Tell your health care team about side-effects you are experiencing so they know how best to help you manage them.
  • Breast enlargement
  • Constipation
  • Diarrhea
  • Difficulty sleeping
  • Fatigue / weakness
  • Headaches
  • Hot flashes
  • Impotence (erectile dysfunction)
  • Nausea
  • Reduced libido (low sex drive)

 
Is Triptorelin Pamoate covered in my province or territory?

Triptorelin pamoate is covered by provincial drug programs in:
  • New Brunswick
  • Newfoundland & Labrador
  • Northwest Territories
  • Nova Scotia
  • Nunavut
  • Ontario
  • Quebec
  • Prince Edward Island
  • Yukon
Triptorelin pamoate is not covered by provincial drug programs in:
  • Alberta
  • British Columbia
  • Manitoba
  • Saskatchewan



 
Last Reviewed: November 2013




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.
More

12 innovative Canadian prostate cancer researchers set out to make new Discoveries

Toronto, ON – September 28, 2017: 12 forward-thinking Canadian prostate cancer researchers have been rewarded for their innovation with Movember Discovery Grants.
More

Gray Tools '2017 Together We Are Stronger' campaign a success in creating awareness and raising funds for prostate cancer

BRAMPTON, Ontario, Sept 26, 2017 (GLOBE NEWSWIRE) -- Gray Tools Canada Inc, in cooperation with Prostate Cancer Canada, is proud to announce that its “2017 Together We Are Stronger” initiative raised $4,000, which will go directly towards funding valuable research that is needed to improve the way we diagnose, treat, and support men living with the disease.
More


Click here for news archive